Inventor · disambiguated record
Marinus Jacobus Verwijs
Also filed as: VERWIJS MARINUS JACOBUS
8 granted patents·23 pending applications·224 citations·filing 2009–2023
89Inventor score
Top patents by PatentIndex Score
31 records- 0197US10646481B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted May 12, 2020·21 cites·26 claims
- 0297US9241934B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2014·Granted Jan 26, 2016·58 cites·37 claims
- 0396US11564916B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2020·Granted Jan 31, 2023·7 cites·40 claims
- 0496US10076513B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2016·Granted Sep 18, 2018·27 cites·49 claims
- 0595US11052075B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2019·Granted Jul 6, 2021·13 cites·22 claims
- 0695US8552034B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERWIJS MARINUS JACOBUS·Filed 2011·Granted Oct 8, 2013·98 cites·55 claims
- 0777US2022031679A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0874US12508231B2Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2021·Granted Dec 30, 2025·0 cites·22 claims
- 0972US2023364073A1Pharmaceutical compositions for the treatment of cftr mediated diseasesVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1068US2020338063A1Pharmaceutical compositions for the treatment of cftr mediated diseasesVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 1166US2024166636A1Crystalline compounds and methods of making the sameEPIZYME INC·Filed 2023·Application pending·0 cites
- 1266US2019070155A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1366US2010074949A1Pharmaceutical composition and administration thereofROWE WILLIAM·Filed 2009·Application pending·0 cites
- 1465US12458635B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2022·Granted Nov 4, 2025·0 cites·17 claims
- 1564US2020085750A1Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 1663US2014023706A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1761US2013095181A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 1859US2018008546A1Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 1959US2014112988A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2058US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2157US2014315948A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2257US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2356US2021221800A1Crystalline compounds and methods of making the sameEPIZYME INC·Filed 2021·Application pending·0 cites
- 2455US2016324788A1Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 2552US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2652US2014163068A1Pharmaceutical Compositions for the Treatment of CFTR Mediated DiseasesVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2752US2012258983A1Pharmaceutical Composition and Administrations ThereofROWE WILLIAM·Filed 2012·Application pending·0 cites
- 2851US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2947US2016324846A1Pharmaceutical Compositions for the Treatment of CFTR Mediated DiseasesVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 3047US2010256184A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 3139US2012220625A1Pharmaceutical composition and administrations thereofROWE WILLIAM·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marinus Jacobus Verwijs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →